Dashboard
1
Poor Management Efficiency with a low ROCE of 4.39%
- The company has been able to generate a Return on Capital Employed (avg) of 4.39% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -3.96% and Operating profit at 22.72% over the last 5 years
3
With ROE of 6.95%, it has a very attractive valuation with a 2.85 Price to Book Value
4
Consistent Returns over the last 3 years
Stock DNA
Commercial Services & Supplies
CNY 51,114 Million (Large Cap)
41.00
NA
1.11%
-0.51
7.56%
5.04
Revenue and Profits:
Net Sales:
1,116 Million
(Quarterly Results - Mar 2026)
Net Profit:
121 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.28%
0%
-0.28%
6 Months
59.07%
0%
59.07%
1 Year
50.13%
0%
50.13%
2 Years
102.26%
0%
102.26%
3 Years
105.28%
0%
105.28%
4 Years
269.42%
0%
269.42%
5 Years
223.91%
0%
223.91%
Wangsu Science & Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.96%
EBIT Growth (5y)
22.72%
EBIT to Interest (avg)
22.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.47
Tax Ratio
8.04%
Dividend Payout Ratio
90.58%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
4.39%
ROE (avg)
3.54%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
2.85
EV to EBIT
44.24
EV to EBITDA
29.62
EV to Capital Employed
8.22
EV to Sales
4.12
PEG Ratio
3.10
Dividend Yield
2.04%
ROCE (Latest)
18.58%
ROE (Latest)
6.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Jun 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,115.70
1,169.00
-4.56%
Operating Profit (PBDIT) excl Other Income
150.70
174.20
-13.49%
Interest
2.80
2.60
7.69%
Exceptional Items
39.60
18.40
115.22%
Consolidate Net Profit
120.80
184.20
-34.42%
Operating Profit Margin (Excl OI)
135.10%
111.60%
2.35%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -4.56% vs 2.43% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -34.42% vs -23.73% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
4,651.80
4,925.40
-5.55%
Operating Profit (PBDIT) excl Other Income
659.80
649.60
1.57%
Interest
16.00
19.30
-17.10%
Exceptional Items
126.60
30.80
311.04%
Consolidate Net Profit
795.20
671.20
18.47%
Operating Profit Margin (Excl OI)
101.90%
77.20%
2.47%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -5.55% vs 4.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 18.47% vs 10.69% in Dec 2024
About Wangsu Science & Technology Co., Ltd. 
Wangsu Science & Technology Co., Ltd.
Commercial Services & Supplies
No Details Available.
Company Coordinates 
No Company Details Available






